Brief: Virios Therapeutics To Report Third Quarter 2022 Financial Results
03/11/2022 11:23
Nov 3 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS TO REPORT THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDE CORPORATE UPDATE ON MONDAY, NOVEMBER 14,
2022
Source text for Eikon: ID:nBw5sFbdka
Further company coverage: VIRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study